Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats

European Journal of Pharmacology

Volumn 564, Issue 1-3, 2007, Pages 150-157

  Agelaki, Maria G ^a   Pantos, Constantinos ^b   Korantzopoulos, Panagiotis ^a   Tsalikakis, Dimitrios G ^c   Baltogiannis, Giannis G ^a   Fotopoulos, Andreas ^a   Kolettis, Theofilos M ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Acute myocardial infarction; Amiodarone; Dronedarone; Mortality; Ventricular arrhythmias

Indexed keywords

AMIODARONE; DRONEDARONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART BEAT; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID FUNCTION;

ACTION POTENTIALS; AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY, AMBULATORY; EPINEPHRINE; FEMALE; MYOCARDIAL INFARCTION; NOREPINEPHRINE; RADIOIMMUNOASSAY; RANDOM ALLOCATION; RATS; RATS, WISTAR; TACHYCARDIA, VENTRICULAR; TELEMETRY; THYROID HORMONES; VENTRICULAR FIBRILLATION;

EID: 34250683781     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.02.052     Document Type: Article

References (41)

1. Aanderud S., Sundsfjord J., and Aarbakke J. Amiodarone inhibits the conversion of thyroxine to triiodothyronine in isolated rat hepatocytes. Endocrinology 115 (1984) 1605-1608
2. Baltogiannis G.G., Tsalikakis D.G., Mitsi A.C., Hatzistergos K.E., Elaiopoulos D., Fotiadis D.I., Kyriakides Z.S., and Kolettis T.M. Endothelin receptor-A blockade decreases ventricular arrhythmias after myocardial infarction in rats. Cardiovasc. Res. 67 (2005) 647-654
3. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., McNulty S.E., Clapp-Channing N., Davidson-Ray L.D., Fraulo E.S., Fishbein D.P., Luceri R.M., and Ip J.H. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352 (2005) 225-237
4. Cheng J.H., and Kodama I. Two components of delayed rectifier K+ current in heart: molecular basis, functional diversity, and contribution to repolarization. Acta Pharmacol. Sin. 25 (2004) 137-145
5. Clements-Jewery H., Hearse D.J., and Curtis M.J. Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation. Br. J. Pharmacol. 145 (2005) 551-564
6. Connolly S.J. Evidence-based analysis of amiodarone efficacy and safety. Circulation 100 (1999) 2025-2034
7. Di Matola T., D'Ascoli F., Fenzi G., Rossi G., Martino E., Bogazzi F., and Vitale M. Amiodarone induces cytochrome c release and apoptosis through an iodine-independent mechanism. J. Clin. Endocrinol. Metab. 85 (2000) 4323-4330
8. Djandjighian L., Planchenault J., Finance O., Pastor G., Gautier P., and Nisato D. Hemodynamic and antiadrenergic effects of dronedarone and amiodarone in animals with a healed myocardial infarction. J. Cardiovasc. Pharmacol. 36 (2000) 376-383
9. Drvota V., Haggblad J., Blange I., Magnusson Y., and Sylven S. The effect of amiodarone on the beta-adrenergic receptor is due to a downregulation of receptor protein and not to a receptor-ligand interaction. Biochem. Biophys. Res. Commun. 255 (1999) 515-520
10. Du X.J., Esler M.D., and Dart A.M. Sympatholytic action of intravenous amiodarone in the rat heart. Circulation 91 (1995) 462-470
11. Finance O., Manning A., and Chatelain P. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, d,l-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. J. Cardiovasc. Pharmacol. 26 (1995) 570-576
12. Franz M.R. Current status of monophasic action potential recording: theories, measurements and interpretations. Cardiovasc. Res. 41 (1999) 25-40
13. Guiraudou P., Pucheu S.C., Gayraud R., Gautier P., Roccon A., Herbert J.M., and Nisato D. Involvement of nitric oxide in amiodarone- and dronedarone-induced coronary vasodilation in guinea pig heart. Eur. J. Pharmacol. 496 (2004) 119-127
14. Horacek T., Neumann M., von Mutius S., Budden M., and Meesmann W. Nonhomogeneous electrophysiological changes and the bimodal distribution of early ventricular arrhythmias during acute coronary artery occlusion. Basic Res. Cardiol. 79 (1984) 649-667
15. Ide T., Tsutsui H., Kinugawa S., Utsumi H., and Takeshita A. Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action. Circulation 100 (1999) 690-692
16. Kadoya M., Konishi T., Tamamura T., Ikeguchi S., Hashimoto S., and Kawai C. Electrophysiological effects of amiodarone on isolated rabbit heart muscles. J. Cardiovasc. Pharmacol. 7 (1985) 643-648
17. Khan M.H. Oral class III antiarrhythmics: what is new?. Curr. Opin. Cardiol. 19 (2004) 47-51
18. Klein I., and Ojamaa K. Thyroid hormone-targeting the heart. Endocrinology 142 (2001) 11-12
19. Kodama I., Suzuki R., Kamiya K., Iwata H., and Toyama J. Effects of long-term oral administration of amiodarone on the electromechanical performance of rabbit ventricular muscle. Br. J. Pharmacol. 107 (1992) 502-509
20. Kodama I., Kamiya K., and Toyama J. Cellular electropharmacology of amiodarone. Cardiovasc. Res. 35 (1997) 13-29
21. Le Bouter S., El Harchi A., Marionneau C., Bellocq C., Chambellan A., van Veen T., Boixel C., Gavillet B., Abriel H., Le Quang K., Chevalier J.C., Lande G., Leger J.J., Charpentier F., Escande D., and Demolombe S. Long-term amiodarone administration remodels expression of ion channel transcripts in the mouse heart. Circulation 110 (2004) 3028-3035
22. Manning A.S., Bruyninckx C., Ramboux J., and Chatelain P. SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. J. Cardiovasc. Pharmacol. 26 (1995) 453-461
23. Mohabir R., Franz M.R., and Clusin W.T. In vivo electrophysiological detection of myocardial ischemia through monophasic action potential recording. Prog. Cardiovasc. Dis. 34 (1991) 15-28
24. Opitz C.F., Mitchell G.F., Pfeffer M.A., and Pfeffer J.M. Arrhythmias and death after coronary artery occlusion in the rat. Continuous telemetric ECG monitoring in conscious, untethered rats. Circulation 92 (1995) 253-261
25. Pantos C., Mourouzis I., Delbruyere M., Malliopoulou V., Tzeis S., Cokkinos D.D., Nikitas N., Carageorgiou H., Varonos D., Cokkinos D., and Nisato D. Effects of dronedarone and amiodarone on plasma thyroid hormones and on the basal and postischemic performance of the isolated rat heart. Eur. J. Pharmacol. 444 (2002) 191-196
26. Pantos C., Malliopoulou V., Varonos D.D., and Cokkinos D.V. Thyroid hormone and phenotypes of cardioprotection. Basic Res. Cardiol. 99 (2004) 101-120
27. Pantos C., Mourouzis I., Malliopoulou V., Paizis I., Tzeis S., Moraitis P., Sfakianoudis K., Varonos D.D., and Cokkinos D.V. Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1. Thyroid 15 (2005) 16-23
28. Pantos C., Mourouzis I., Saranteas T., Paizis I., Xinaris C., Malliopoulou V., and Cokkinos D.V. Thyroid hormone receptors alpha1 and beta1 are downregulated in the post-infarcted rat heart: consequences on the response to ischaemia-reperfusion. Basic Res. Cardiol. 100 (2005) 422-432
29. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., Fletcher P.J., Spadaro J., Kloner R.A., and Braunwald E. Myocardial infarct size and ventricular function in rats. Circ. Res. 44 (1979) 503-512
30. Priori S.G., and Napolitano C. Intracellular calcium handling dysfunction and arrhythmogenesis: a new challenge for the electrophysiologist. Circ. Res. 97 (2005) 1077-1079
31. Rees S.A., and Curtis M.J. Selective IK blockade as an antiarrhythmic mechanism: effects of UK66,914 on ischaemia and reperfusion arrhythmias in rat and rabbit hearts. Br. J. Pharmacol. 108 (1993) 139-145
32. Rochetaing A., Barbe C., and Kreher P. Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters assessed during reperfusion in isolated rat hearts. J. Cardiovasc. Pharmacol. 38 (2001) 500-511
33. Rooney R.T., Marijic J., Stommel K.A., Bosnjak Z.J., Aggarwal A., Kampine J.P., and Stowe D.F. Additive cardiac depression by volatile anesthetics in isolated hearts after chronic amiodarone treatment. Anesth. Analg. 80 (1995) 917-924
34. Singh S. Trials of new antiarrhythmic drugs for maintenance of sinus rhythm in patients with atrial fibrillation. J. Interv. Card. Electrophysiol. 10 Suppl 1 (2004) 71-76
35. Sogol P.B., Hershman J.M., Reed A.W., and Dillmann W.H. The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5′-monodeiodination in rats. Endocrinology 113 (1983) 1464-1469
36. Tsalikakis D.G., Fotiadis D.I., Kolettis T., and Michalis L.K. Automated system for the analysis of heart monophasic action potentials. Comput. Cardiol. 30 (2003) 339-342
37. van Opstal J.M., Schoenmakers M., Verduyn S.C., de Groot S.H., Leunissen J.D., van Der Hulst F.F., Molenschot M.M., Wellens H.J., and Vos M.A. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Circulation 104 (2001) 2722-2727
38. Varro A., Takacs J., Nemeth M., Hala O., Virag L., Iost N., Balati B., Agoston M., Vereckei A., Pastor G., Delbruyere M., Gautier P., Nisato D., and Papp J.G. Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone. Br. J. Pharmacol. 133 (2001) 625-634
39. Walker M.J., Curtis M.J., Hearse D.J., Campbell R.W., Janse M.J., Yellon D.M., Cobbe S.M., Coker S.J., Harness J.B., and Harron D.W. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc. Res. 22 (1988) 447-455
40. Wellens H.J. Cardiac arrhythmias: the quest for a cure: a historical perspective. J. Am. Coll. Cardiol. 44 (2004) 1155-1163
41. Ytrehus K., Liu Y., Tsuchida A., Miura T., Liu G.S., Yang X.M., Herbert D., Cohen M.V., and Downey J.M. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am. J. Physiol. 267 (1994) H2383-H2390